
Benzocal-50 is an advanced enteric-release formulation containing ≥50% benzoic acid. Utilizing pH-sensitive ion-exchange resin technology, it is designed to minimize premature release and absorption in the upper gastrointestinal tract, enabling targeted delivery to the distal intestine.
Unlike conventional benzoic acid, which is rapidly absorbed in the upper gastrointestinal tract, Benzocal-50 supports localized intestinal action, helping reduce pathological intestinal fluid secretion, improve fecal consistency, and maintain intestinal health.
Its targeted-release technology also allows lower recommended inclusion rates compared with conventional benzoic acid, offering a cost-effective solution for modern animal production.
Key Benefits
1. Targeted Intestinal Release: pH-sensitive ion-exchange resin technology enables controlled benzoic acid delivery to the distal intestinal tract.
2. Pathological Secretion Control: Helps reduce excessive intestinal fluid secretion and watery diarrhea, supporting intestinal fluid balance.
3. Improved Safety & Feed Intake: Reduced systemic absorption may help minimize hepatic exposure, while maintaining feed intake at tested high inclusion levels.
4. Cost-effective Performance: Supports intestinal health and animal performance at lower recommended inclusion rates compared with conventional benzoic acid.
Applications: Poultry, swine, and other livestock species.